Dopamine in substantia nigra and cortex after γ-butyrolactone treatment
- 1 June 1976
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 28 (6) , 527-530
- https://doi.org/10.1111/j.2042-7158.1976.tb02784.x
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Dopamine receptor binding: Differentiation of agonist and antagonist states with 3H-dopamine and 3H-haloperidolLife Sciences, 1975
- Dopamine in dendrites of substantia nigra neurons: suggestions for a role in dendritic terminalsBrain Research, 1975
- Histochemical confirmation for dopaminergic innervation of the rat cerebral cortex after destruction of the noradrenergic ascending pathwaysBrain Research, 1974
- The effect of dopamine and of apomorphine on dB-cAMP-induced stimulation of synaptosomal tyrosine hydroxylaseJournal of Pharmacy and Pharmacology, 1974
- Chemical or electrolytic lesion of the substantia nigra: Early effects on neostriatal dopamine metabolismBrain Research, 1974
- CATECHOLAMINES IN FETAL AND NEWBORN RAT BRAINJournal of Neurochemistry, 1973
- Effects of drugs influencing monoamine mechanisms on the increase in brain dopamine produced by axotomy or treatment with gammahydroxybutyric acidNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1973
- Distribution of noradrenaline nerve terminals in cortical areas of the ratBrain Research, 1968
- Selective increase of brain dopamine induced by gamma-hydroxybutyrateLife Sciences, 1966
- Effect of Chlorpromazine or Haloperidol on Formation of 3‐Methoxytyramine and Normetanephrine in Mouse BrainActa Pharmacologica et Toxicologica, 1963